Clinical Trials for Endocarditis
This article provides information about ongoing clinical trials investigating new approaches to diagnosing and treating endocarditis, a serious infection of the heart’s inner lining and valves. Currently, there are 2 clinical trials exploring different aspects of this condition, from improved diagnostic imaging techniques to optimized antibiotic treatment strategies.
Clinical trial locations
- France
- Sweden
Study on Gallium Citrate Ga-68 PET/CT for Diagnosing Prosthetic Valve Infective Endocarditis in Patients Suspected of Having the Condition
This trial, conducted in France, focuses on improving the diagnosis of infections that occur in patients with artificial heart valves. The study uses an advanced imaging technique called PET/CT combined with a special substance called Gallium 68 citrate, which helps doctors see detailed images of the heart and detect infections more accurately.
Main inclusion criteria: To participate in this study, you must be an adult over 18 years old with a prosthetic heart valve who is suspected of having an infection of the heart’s inner lining based on clinical signs, laboratory tests, or imaging results. Your case must be reviewed in a multidisciplinary meeting with healthcare specialists, and you need to be part of a social security program. You must also provide informed written consent after understanding the study details.
Main exclusion criteria: The trial information does not specify particular exclusion criteria beyond the standard requirements for safe participation in medical imaging studies.
Study focus: The main goal of this trial is to determine how effective the 68Ga-PET/CT scan is in diagnosing infections in patients with artificial heart valves. Researchers will compare the results of this new imaging method with another technique called 18FDG-PET/CT to see which provides better information about the infection. The study will also examine how consistent the results are when different doctors review the scans, helping to improve diagnosis and treatment of these serious heart infections.
Investigational drug: The study uses Gallium 68 citrate, which is injected into the body intravenously. This imaging agent highlights areas of infection and inflammation during the PET/CT scan, allowing doctors to see if there is an infection on or around the artificial heart valve more clearly than with standard imaging methods.
Study on Shortened Antibiotic Treatment for Infectious Endocarditis Using Vancomycin, Meropenem, and Ceftriaxone for Patients with Left-Sided Heart Infection
This clinical trial, taking place in Sweden, examines whether a shorter course of antibiotic treatment can safely and effectively treat serious heart infections. The study specifically targets infections on the left side of the heart caused by certain bacteria.
Main inclusion criteria: Participants must be adults over 18 years old who are hospitalized with left-sided endocarditis confirmed according to modified Duke’s criteria. The infection must be caused by one of three specific types of bacteria: Staphylococcus aureus, streptococci, or Enterococcus faecalis. You must provide informed consent after being fully informed about the study.
Main exclusion criteria: You cannot participate if your infection is caused by bacteria other than the three specified types. Patients outside the specified age range or who are part of a vulnerable population are also excluded from participation.
Study focus: The primary goal is to evaluate whether a shorter duration of antibiotic treatment is as safe and effective as the standard longer treatment courses typically used. Researchers will monitor participants for up to six months, tracking important outcomes such as death, septic embolization (when infected particles travel through the bloodstream and block blood vessels), infection recurrence, and the need for heart surgery. The study will also examine hospital costs, length of hospital stay, treatment duration, and complications related to intravenous medication administration.
Investigational drugs: The trial uses several antibiotics administered intravenously, including Vancomycin, Meropenem, Ceftriaxone, Benzylpenicillin, Ampicillin, Cloxacillin, Cefotaxime, and Daptomycin. These medications work by targeting and killing bacteria or stopping their growth, helping the body’s immune system clear the infection. Some participants may receive a combination of these antibiotics, while others may receive a placebo as part of the study design.
Summary
Currently, there are two ongoing clinical trials addressing different aspects of endocarditis care. One trial in France focuses on improving diagnostic capabilities for patients with prosthetic valve infections using advanced imaging technology with Gallium 68 citrate. The other trial in Sweden investigates whether shorter antibiotic treatment courses can effectively treat bacterial heart infections, potentially reducing hospital stays and healthcare costs.
These studies reflect the diverse approaches needed to address endocarditis, from accurate diagnosis to optimized treatment strategies. The French trial targets a specific population with artificial heart valves, while the Swedish study focuses on left-sided infections caused by particular bacterial strains. Together, these trials aim to improve outcomes for patients facing this serious heart condition through better diagnosis and more efficient treatment protocols.
